1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hypoproteinemia: new trials by email Literature Review of Hypoproteinemia trials Research Report on Hypoproteinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection in Healthy Trial Participants and Cirrhotic Trial Participants With Ascites and Hypoalbuminemia placebo GLR1075 Vehicle, Human Serum Albumin(HSA), GLR1075 Injection - Hypoalbuminemia in Cirrhotic Ascites | Phase 1 | Not yet recruiting | Gan & Lee Pharmaceuticals. | 106 | 2026-10-07 | 2026-10-01 |
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease | Phase 1 / Phase 2 | Completed | University of Aarhus | 57 | 2021-03-25 | 2025-04-11 |
Hypoalbuminemia (2) · Glomerulonephritis (1) · Glomerulonephritis, Membranous (1) · Nephrotic Syndrome (1) · Proteinuria (1) · Thromboembolism (1)
Blood Protein Disorders (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Nephrosis (1) · Pathological Conditions, Signs and Symptoms (1)
Dalteparin (1) · Serum Albumin, Human (1) · apixaban (1)
Gan & Lee Pharmaceuticals. (1) · University of Aarhus (1)
China (1) · Denmark (1)